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Wnt-4 and Ets-1 signaling
pathways for regeneration
after acute renal failure
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University, Tokyo, Japan
Ischemic acute renal failure (ARF) is the most common form
of ARF in the adult population. The molecular mechanisms of
tubular regeneration after ischemic renal injury remain largely
unknown. An understanding of the mechanisms that lead to re-
nal cell proliferation and regeneration will be necessary for the
exploration of novel therapeutic strategies for the treatment of
ARF. It has been suggested that regeneration processes may
recapitulate developmental processes in order to restore organ
or tissue function. The adult tubular epithelial cells have a po-
tent ability of regenerate after cellular damage. We examined
functional role of two developmental genes, Wnt-4 and Ets-1,
in renal tubular regeneration in ARF. The Wnt-b-catenin path-
way plays key roles in embryogenesis. Wnt-4 is known to be
expressed in the mesonephric duct in the embryonic develop-
ment. To clarify the significance of the Wnt-4-b-catenin path-
way in ARF, we used a rat ARF model in vivo and LLC-PK1
cells as an in vitro model. After clamping left rat renal artery
for 1 hour, we examined whole kidney homogenate and total
RNA extracted at 3, 6, 12, 24, 48, and 72 hours after reperfusion
by Western blot analysis and real-time reverse transcription-
polymerase chain reaction (RT-PCR). Wnt-4 mRNA and pro-
tein expression were strongly increased at 3 to 12 hours and 6 to
24 hours after ischemia, respectively. In immunohistologic ex-
amination, Wnt-4 was expressed in the proximal tubules and
coexpressed with aquaporin 1 and proliferating cell nuclear
antigen (PCNA). Cyclin D1 and cyclin A were expressed at
12 to 48 hours after reperfusion. Furthermore, overexpression
of Wnt-4 and b-catenin promoted the cell cycle and increased
the promoter activity and protein expression of cyclin D1 and
cyclin A in LLC-PK1 cells. These data suggest that the Wnt-4-
b-catenin pathway plays a key role in the cell cycle progression
of renal tubules in ARF. The Ets family of transcription fac-
tors is defined by a conserved DNA-binding Ets domain that
forms a winged helix-turn-helix structure motif. The Ets family
is involved in a diverse array of biologic functions, including
cellular growth, migration, and differentiation. To clarify the
significance of Ets-1 in ARF, we used a rat ARF model in vivo
and LLC-PK1 cells as an in vitro model. Ets-1 mRNA and pro-
tein expression were strongly increased at 3 to 12 hours and 6 to
24 hours after the ischemia, respectively. In the immunohisto-
logic examination, Ets-1 was expressed in the proximal tubules
and coexpressed with PCNA. Furthermore, overexpression of
Ets-1 promoted the cell cycle and increased the promoter ac-
tivity and protein expression of cyclin D1 in LLC-PK1 cells.
Ets-1 promoter activity increased between 3 hours and 6 hours
in hypoxia, and hypoxia also induced changes in the Ets-1 pro-
tein level in LLC-PK1 cells. Taken together, these data suggest
that Ets-1 plays a key role in the cell cycle progression of renal
tubules in ARF. Our data suggest that Wnt-4-b-catenin and Ets-
1 pathways regulate the transcription of cyclin D1 and control
the regeneration of renal tubules in ARF. These developmental
genes may play key roles in dedifferentiation and regeneration
of the renal tubular cells after ARF.
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Kidneys can recovery from some type of injury. After an
acute glomerulonephritis or a short-term ischemia, damaged
glomerulus or tubules recover their normal structures with pro-
liferation of the survived cells and infiltration of extrarenal cells.
On the other hand, a prolonged or continuous injury leads to
a progressive renal disease. We have investigated molecular
events in reversible and irreversible renal diseases and have
made efforts to identify genes pivotal in promoting regeneration
or progression of the renal diseases. To identify genes responsi-
ble for kidney regeneration, we surveyed the expression pattern
of the “development” genes in ischemia-reperfusion model of
rat kidney. The regeneration, molding, and maturation of the
restored epithelium after renal ischemia injury have many par-
allels to the growth and maturation that takes place during kid-
ney organogenesis. We found that leukemia inhibitory factor
(LIF) and its receptor (LIFR) expression were up-regulated
during the recovery phase after ischemia insult. The increased
expression of LIF and LIFR was most marked in the outer
medulla, especially in the S3 segment of the proximal tubules.
In cultured rat renal epithelial NRK52E cells, LIF expression
was enhanced during recovery after adenosine triphosphate
(ATP) depletion. Blockade of endogenous LIF with a neutral-
izing antibody significantly reduced the cell number and DNA
synthesis during the recovery period. These results suggest that
LIF participates in the regeneration process after tubular injury
[Yoshino J, Monkawa T, Tsuji M, et al: Leukemia inhibitory fac-
tor is involved in tubular regeneration after experimental acute
renal failure. J Am Soc Nephrol 14:3090–3101, 2003]. To search
for genes playing important roles in progression of renal dis-
eases, we compared gene expression profiles between an irre-
versible model and a reversible model of anti-Thy-1 glomeru-
lonephritis using a microarray technology. A single intravenous
injection of anti-Thy-1 monoclonal antibody 1-22-3 is known
to cause a reversible mesangial proliferative glomerulonephri-
tis. However, monoclonal antibody 1-22-3 injection followed
by unilateral nephrectomy leads to progressive glomeruloscle-
rosis with an irreversible course. Among 4854 rat genes on the
microarray slide, 189 genes were differentially expressed. The
differentially expressed genes were classified into five clusters
based on their expression patterns. One of the clusters included
genes the expression of which was markedly up-regulated in
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the irreversible model. The expression levels of the genes be-
longing to the cluster were low in normal kidney and increased
along with disease peaked at day 14, and the up-regulation was
more pronounced in the irreversible model than the reversible
model. This cluster included collagen type1, laminin, osteopon-
tin, kidney injury molecule-1 (KIM-1), and thymosin b10. These
molecules can be new therapeutic targets for slowing the pro-
gression of renal diseases or accelerating repair of the injured
kidney.
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Reversing EMT
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Epithelial-mesenchymal transition (EMT) is a process
whereby epithelial cell layers lose polarity and cell-cell contacts
and undergo a massive cytoskeleton reorganization involving
the rho family and the remodeling of the actin microfilament
mesh (Thiery, 2002). Concurrent with a loss of epithelial cell
adhesion and cytoskeletal components, cells undergoing EMT
acquire expression of mesenchymal components and manifest
a migratory phenotype. This is a fundamental process govern-
ing morphogenesis in multicellular organisms during embryonic
development. This EMT process, first appreciated by develop-
mental biologists in the early 1980s, is now attracting increasing
attention from oncologists and nephrologists, because the pro-
cess is also reactivated in a variety of diseases, including fibrosis
and in the progression of carcinoma. From a therapeutic stand-
point, it may be important to reverse EMT in these diseases.
EMT is characterized by coordinated changes in cell mor-
phology, associated with the induction of cell motility and the
disruption of intercellular junctions. In some cases, cells under-
going EMT start synthesizing extracellular matrix molecules
such as fibronectin and certain types of collagen. They may also
synthesize proteolytic enzymes involved in matrix degradation
that contribute to cell motility and invasiveness. It should be
stressed that not all EMTs exhibit the whole range of changes
listed here. However, EMT is always associated with cell scat-
tering, defined by the loss of intercellular junctions and acqui-
sition of cell motility. The transformation of mesenchyme to
epithelium (MET), the reverse of EMT, also occurs during em-
bryonic development. The differentiation of the metanephric
blastema provides a striking example of MET. The cardinal
feature of kidney development is the formation of epithelial
tubules from nonepithelial mesenchymal cells. This conversion
of cell type, MET, is controlled by factors secreted from the
ureteric bud (Barasch, 1999; Plisov, 2001), and these epithe-
lial inducers have been purified from ureteric bud cell lines
(Barasch, 1996). These molecules are endogeneous MET induc-
ers. We have tested some of these [bone morphogenetic protein
7(BMP-7) and lipocalin 2] for their epithelial inducing activities
in the context of tumor biology and fibrosis and these results
with potential therapeutic applications have been discussed.
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Up-regulation in the kidney
and its genetic polymorphism
of MUC20, a regulator of Met
signaling cascade, in patients
with IgA nephropathy
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MUC20, a novel mucin protein highly expressed in kidney,
was isolated as an up-regulated gene in renal tissues of pa-
tients with IgA nephropathy (IgAN) (J Biol Chem 279:1968,
2004). Functional analyses of MUC20 have demonstrated its
role as a negative regulator of hepatocyte growth factor (HGF)–
induced Grb2-Ras pathway. The C-terminus of MUC20 asso-
ciates with the multifunctional docking site of Met, preventing
Grb2 recruitment to Met and thus attenuating HGF-induced
proliferation and matrix metalloproteinase expression (Mol
Cell Biol 24:7456, 2004). In addition, it has been suggested that
the oligomerization of MUC20, caused by its overproduction or
some other unknown factor(s), which leads to this association
with Met. Interestingly, in human MUC20, the repeat numbers
of the extracellular tandem domain, which may have an influ-
ence on the oligomerization, showed a divergence, with two to
six repeat types in several human cell lines. In this study, to
clarify the role of MUC20 in human kidney diseases, we ana-
lyzed the expression of MUC20 in kidney tissues of patients with
IgAN by in situ hybridization. We also investigated the possible
association of the tandem repeat polymorphism of MUC20 with
renal survival in 236 patients with histologically proven IgAN.
In normal kidneys, the expression of MUC20 was confined to
the distal tubules, where Met was colocalized by immunohsito-
chemistry. In addition, glomerular podocytes and the parietal
epithelial cells lining Bowman’s capsule demonstrated positive
expression of MUC20. In renal tissues of IgAN, up-regulation
of MUC20 expression in proximal tubules, as well as in distal
tubules, was observed. By Kaplan-Meier analysis, the prognosis
of IgAN patients with five or six of tandem repeat of MUC20
(N = 130) was significantly better than those without (N =
106, log-rank, v 2 = 10.51) (P = 0.0012). The tandem repeat
polymorphism of MUC20 was an independent risk factor for
